UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2 mg/day, but does not enhance efficacy of haloperidol, 2 mg/day: Comparison with reference dose risperidone, 6 mg/day

Schizophrenia research, 2012-11, Vol.141 (2), p.144-152

2012

Link zum Volltext

Verfügbarkeit prüfen

Empirical Validation of Primary Negative Symptoms: Independence From Effects of Medication and Psychosis

The American journal of psychiatry, 1999-03, Vol.156 (3), p.406-411

1999

Link zum Volltext

Verfügbarkeit prüfen

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status

The American journal of psychiatry, 1995-09, Vol.152 (9), p.1291-1297

1995

Link zum Volltext

Verfügbarkeit prüfen

Elevated interleukin-6 in schizophrenia

Psychiatry research, 1999-10, Vol.87 (2), p.129-136

1999

Link zum Volltext

Verfügbarkeit prüfen

Relations between Cognitive and Symptom Profile Heterogeneity in Schizophrenia

The journal of nervous and mental disease, 1999-07, Vol.187 (7), p.414-419

1999

Link zum Volltext

Verfügbarkeit prüfen

Factor structure of neurologic examination abnormalities in unmedicated schizophrenia

Psychiatry research, 2000-09, Vol.95 (3), p.237-243

2000

Link zum Volltext

Verfügbarkeit prüfen

A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia

Psychopharmacology, 1996-03, Vol.124 (1-2), p.168-175

1996

Link zum Volltext

Verfügbarkeit prüfen

The effects of antipsychotic medication on factor and cluster structure of neurologic examination abnormalities in schizophrenia

Schizophrenia research, 2005-06, Vol.75 (1), p.55-64

2005

Link zum Volltext

Verfügbarkeit prüfen

Plasma Catecholamine Metabolites as Markers for Psychosis and Antipsychotic Response in Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 1999-06, Vol.20 (6), p.603-611

1999

Link zum Volltext

Verfügbarkeit prüfen

Influence of haloperidol on the relationship of frontal lobe function to psychomotor poverty and disorganization syndromes

Psychiatry research, 2000-02, Vol.93 (1), p.33-39

2000

Link zum Volltext

Verfügbarkeit prüfen

Utility of WAIS-R short forms in schizophrenia

Schizophrenia research, 1997-08, Vol.26 (2), p.163-172

1997

Link zum Volltext

Verfügbarkeit prüfen

GABA and brain abnormalities in schizophrenia

Psychiatry research, 1998-04, Vol.82 (1), p.25-35

1998

Link zum Volltext

Verfügbarkeit prüfen

CSF dopamine beta-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures

The American journal of psychiatry, 1994-03, Vol.151 (3), p.372-378

1994

Link zum Volltext

Verfügbarkeit prüfen

Inter-rater reliability of the neurological examination in schizophrenia

Schizophrenia research, 1998-02, Vol.29 (3), p.287-292

1998

Link zum Volltext

Verfügbarkeit prüfen

A 39-Year Followup of the Genain Quadruplets

Schizophrenia bulletin, 2000-01, Vol.26 (3), p.699-708

2000

Link zum Volltext

Verfügbarkeit prüfen

CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients

The American journal of psychiatry, 1984-04, Vol.141 (4), p.566-569

1984

Link zum Volltext

Verfügbarkeit prüfen

Neuropsychiatric Symptoms Associated with Idiopathic Calcification of the Basal Ganglia

The journal of nervous and mental disease, 1991-01, Vol.179 (1), p.48-49

1991

Link zum Volltext

Verfügbarkeit prüfen

Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment

Archives of general psychiatry, 1997-01, Vol.54 (1), p.49

1997

Link zum Volltext

Verfügbarkeit prüfen

Memory and plasma HVA changes in schizophrenia: Are they episode markers?

Biological psychiatry (1969), 1994-02, Vol.35 (3), p.203-206

1994

Link zum Volltext

Verfügbarkeit prüfen

Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy

Archives of general psychiatry, 1986-10, Vol.43 (10), p.978

1986

Link zum Volltext

Verfügbarkeit prüfen

Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers

The American journal of psychiatry, 1981-11, Vol.138 (11), p.1457-1462

1981

Link zum Volltext

Verfügbarkeit prüfen

CSF chromogranin A-like immunoreactivity in schizophrenia: Relationships with REM latency and slow wave sleep

Psychiatry research, 1992-04, Vol.42 (1), p.53-63

1992

Link zum Volltext

Verfügbarkeit prüfen

Immunoglobulins and Viral Antibodies in Psychiatric Patients

British journal of psychiatry, 1978-04, Vol.132 (4), p.342-348

1978

Link zum Volltext

Verfügbarkeit prüfen

Smooth pursuit eye movement disorder and its psychobiologic correlates in unmedicated schizophrenics

Biological psychiatry (1969), 1986-10, Vol.21 (12), p.1167-1174

1986

Link zum Volltext

Verfügbarkeit prüfen

Reduced cyclic AMP production in the blood platelets from schizophrenic patients

The American journal of psychiatry, 1979-05, Vol.136 (5), p.685-687

1979

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

KollektionEbook Central Perpetual and DDA

ThemaPsychiatric Status Rating Scales

ThemaSocial Sciences

ThemaPsychiatry

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Humans
(35)
Adult
(31)
Male
(30)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Psychology. Psychoanalysis. Psychiatry
(23)
Female
(20)
Schizophrenia
(20)
Psychopathology. Psychiatry
(18)
Schizophrenic Psychology
(18)
Middle Aged
(17)
Schizophrenia - Drug Therapy
(13)
Adult And Adolescent Clinical Studies
(12)
Psychoses
(12)
Schizophrenia - Diagnosis
(11)
Schizophrenia - Cerebrospinal Fluid
(9)
Neuropharmacology
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2 mg/day, but does not enhance efficacy of haloperidol, 2 mg/day: Comparison with reference dose risperidone, 6 mg/day

Empirical Validation of Primary Negative Symptoms: Independence From Effects of Medication and Psychosis

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status

Elevated interleukin-6 in schizophrenia

Relations between Cognitive and Symptom Profile Heterogeneity in Schizophrenia

Factor structure of neurologic examination abnormalities in unmedicated schizophrenia

A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia

The effects of antipsychotic medication on factor and cluster structure of neurologic examination abnormalities in schizophrenia

Plasma Catecholamine Metabolites as Markers for Psychosis and Antipsychotic Response in Schizophrenia

Influence of haloperidol on the relationship of frontal lobe function to psychomotor poverty and disorganization syndromes

Utility of WAIS-R short forms in schizophrenia

GABA and brain abnormalities in schizophrenia

CSF dopamine beta-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures

Inter-rater reliability of the neurological examination in schizophrenia

A 39-Year Followup of the Genain Quadruplets

CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients

Neuropsychiatric Symptoms Associated with Idiopathic Calcification of the Basal Ganglia

Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment

Memory and plasma HVA changes in schizophrenia: Are they episode markers?

Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy

Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers

CSF chromogranin A-like immunoreactivity in schizophrenia: Relationships with REM latency and slow wave sleep

Immunoglobulins and Viral Antibodies in Psychiatric Patients

Smooth pursuit eye movement disorder and its psychobiologic correlates in unmedicated schizophrenics

Reduced cyclic AMP production in the blood platelets from schizophrenic patients

Aktive Filter

Suchergebnisse filtern